NGFR and Alzheimer disease: Studies that include the blockade of p75NTR signaling as a therapeutic step during AD progression might help to counteract the degeneration of cholinergic neurons, altered neuronal network dynamics, and, hence, the cognitive dysfunction typical of AD.